ESMA targets investment firms with MiFID II cross-selling guidance

Must identify risks and costs of bundled products

Daniel Flynn
clock

Investment firms must clearly display the estimated price of separate products ahead of purchase when cross-selling under MiFID II, the European Securities & Markets Authority (ESMA) has ruled.

In its final guidelines on cross-selling practices under the Markets in Financial Instruments Directive II (MiFID II), ESMA - which is responsible for turning MiFID II into legislation - added the information firms use to make estimations must be in accordance with European Union law. The risks of the separate and combined products must also be clearly laid out to customers, in a way which is not misleading. Under MiFID II, cross-selling means the offering of an investment service together with another service or product as part of a package, or as a condition for the same agreement o...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

Trustpilot